Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C

Area of Science:

• Hepatology
• Gastroenterology
• Iron Metabolism

Background:

• Chronic hepatitis C (CHepC) often involves hepatic iron overload, but the mechanisms of iron-induced liver injury remain unclear.
• The specific roles of iron deposition in hepatocytes (HC) and reticuloendothelial cells (REC) in CHepC pathogenesis require further investigation.

Purpose of the Study:

• To investigate the significance of iron deposition patterns in hepatocytes and reticuloendothelial cells in chronic hepatitis C.
• To explore the relationship between iron deposition, liver injury markers, inflammation (sTNFR2), hepcidin expression, and phlebotomy efficacy in CHepC patients.

Main Methods:

• Quantified stainable hepatic iron deposition patterns in 373 CHepC patients.
• Assessed serum soluble TNF-α receptor 2 (sTNFR2) levels, hepatic hepcidin mRNA, and serum ferritin.
• Compared clinical outcomes and phlebotomy efficacy across different iron deposition patterns.

Main Results:

• Patients with REC iron staining exhibited higher serum transaminase levels and more advanced liver disease (stage, grade, steatosis).
• REC iron scores were independently associated with advanced liver stage and elevated serum sTNFR2 levels.
• Iron overload correlated with decreased hepcidin mRNA to ferritin ratios, and phlebotomy was more effective in patients with REC iron.

Conclusions:

• Reticuloendothelial cell iron deposition plays a significant role in the development and progression of chronic hepatitis C.
• Phlebotomy demonstrates therapeutic efficacy in CHepC, particularly in patients with significant iron accumulation in RECs.